New technologies in biopharmaceutical processes BioTech Vaccines Plasma
|
|
- Christine Potter
- 5 years ago
- Views:
Transcription
1 New technologies in biopharmaceutical processes BioTech Vaccines Plasma Dominik Arnold
2 Challenges in Down Stream Processing Higher. Titers >4 g/l Yield > 90% Protein concentration >200 g/l Throughput > 24 h Process flexibility multipurpose Utilization > 3 batches/week Qualification / Validation ICH Qxx Automation GAMP 4/Part 11 Standardisation Platforms
3 Upstream Processing Media Filtration Exhaust Cell Harvest and Product Separation Buffer Filter Liquid Prefilter Aeration Sterilizing-grade Liquid Filter Air Sterilizing-grade Prefilter Air Filter Bioreactor Air Prefilter Sterilizing-grade Air Filter Depth Filtration Tangential Flow Filtration Centrifuge Downstream Processing and Purification Buffer Filter Buffer Filter Buffer Filter Buffer Filter Polishing Chromatography Sterilizing-grade Liquid Filter Sterilizing-grade Liquid Filtration Formulation and Filling Concentration Diafiltration Capture Chromatography Concentration Diafiltration Purification Chromatography Concentration Diafiltration Virus Removal Filtration
4
5 Subprocesses in Down Stream Processing (DSP) Harvest/ Separation Capturing/ Concentration Purification/ Polishing Filtration Clarification Concentration Purification Virus Filtration Separation Capturing Polishing Sterile Filtration
6 Harvest/ Separation Clarification Separation Picture courtesy of Biocon
7 Alternative Harvest Schemes Fermenter Pre-Separation Depth-filtration Clarification Volume, Concentration, Price
8 Alternative Harvest Schemes - Small scale - Low solid load / cell density - Low viscosity - Low investment cost - All scale - All solid load / cell density - Medium viscosity - Medium investment cost - All scale - All solid load / cell density - High viscosity - High investment cost
9 Project example separation and clarification End-user Eng. company Design URS Basic engineering Layout utilities Manufactu ring Installation / Commissi oning Supervisio n Supervisio n Software implementat ion Overall facility Pall Detail engineering FS Mech/ electrical manuf&ass embly Skid Qualificati PQ Joint OQ DQ, IQ, on joint OQ Well defined process allow complex SCADA implementation Early definition of requirements allows process and operator optimized solution Engineering company insures layout and utility fit to purpose
10 Capturing/ Concentration Concentration Capturing Picture courtesy of Lonza
11 Chromatography Process Pump Column UV mv Buffer Process ph Waste Product Detector Stationary Phase Speed Capturing Mobile Phase Selectivity
12 Capturing Capacity, Yield and Resolution Column chromatography Sorbent packing (no channelling, no fine) Identical flow distribution (no preferential flow) Process control (Automation, Instrumentation) Good flow distribution, minimal pressure drop, reliable packing
13
14 Project example In-line buffer dilution Reduce buffer storage for chromatography process In-line buffer mixing reduce buffer storage size by up to 20 times Reduce clean room size Reduce preparation time Simplify chromatography process system Possibility to include single use technologies due to reduced volumes Close coordination with engineering company engineering buffer management and WFI supply
15 Capturing/ Concentration Concentration Capturing Picture courtesy of GSK Bio
16 Typical Tangential Flow Process (TFF) Filtrate Diafiltation Recirculation Vessel Filtration Device Pump Feed Retentate Control Valve Filtrate/Permeate Cross Flow (CFF) Feed Retentate Transmembrane Pressure Filtrate/Permeate Filtrate Flux
17 Critical Parameter in TFF MEMBRANE CONTROLLED REGION GEL LAYER CONTROLLED REGION Filtrate Flux Rate OPTIMAL Cross Flow CF3 (Δ P 3 ) CF2 (Δ P 2 ) CF1 (Δ P 1 ) CF = CROSS FLOW VELOCITY CF 3 > CF 2 > CF 1 Transmembrane Pressure Cross Flow Membrane area, Pressure, Heat intake, Piping, Pump size
18 Disposable Technologies Flexibility and short start up time Low fix cost High variable cost Engineering Concept Standardised Technologies Standard Hardware/ Software Proven Process limitations Customised Technologies Customised Challenges specifications and qualification/validation
19 Level 1 Manual Control Automation Level 2 Setpoint Control Level 3 Sequence Control Intervention, Flexibility, Reliability, Documentation
20 Project example Concentration Product loss, yield High protein concentration (200 g/l) Ensure low protein adsorption on membrane Right pump selection to ensure process consistency at variable viscosity (up to 150 cp) Jacketed tank to maintain temperature Tank in tank design to achieve highest possible concentration Improved pipe design to ensure complete product recovery Optimized tank design to avaoid aggregation and foaming problems
21 Purification/ Polishing Purification Polishing Picture courtesy of Biogen Idec
22 Challenges in Polishing Speed Membrane Chromatography Removal of, DNA / RNA, Endotoxins,Plasmids Minimal fix cost Sterile process conditions Less consumable (buffer/cip) Polishing Speed, Selectivity, Purity
23 Filtration Virus Filtration Sterile Filtration Picture courtesy of Lonza
24 Challenges in Filtration Bioburden vers Sterility Bioburden control Sterile filter Prefiltration steps Column protection Buffer prior chromo Diafiltration - High throughput - Reduced validation - Less filter testing - Smaller sizing Before storage Sterile media End of DSP Filling - Sterility - Integrity testing - Low adsorption
25 Disposable Technologies Cleanable Disposable
26 Pro s and Con s of Disposable Systems Pro s Low installation cost Low cleaning costs and validation No assembly/maintenance costs Small footprints Minimize cross contamination Minimize operator exposure Con s Limitations on scale Limited automation Running cost Limited equipment and instrumentation Limited process pressure
27 Comparison Conventional SS versus Disposable Investment costs % lower Less and smaller equipment, smaller footprint, less utilities, shorter project time Utility costs % lower No steam, No CIP, less WFI/PW Running costs 5-30 % higher More consumables, less automation > higher labour cost Process time % lower Lower preparation cost (SIP and CIP) Business decision Scale, batches/a, new/existing plant
28 Conclusion batch size titer utilization buffer/utility consumption documentation CIP SIP purity product loss/ yield level of automation foot print fix vs running cost
Emerging and Enabling Technologies in Membrane Separations
Emerging and Enabling Technologies in Membrane Separations Andrew L. Zydney Distinguished Professor of Chemical Engineering The Pennsylvania State University 2 nd International Symposium on Continuous
More informationIntroduction to TFF. Sengyong Lee Ph.D. Professor/ Program Chair Biotechnology/ Biology Ivy Tech Community College Bloomington, Indiana
Introduction to TFF Sengyong Lee Ph.D. Professor/ Program Chair Biotechnology/ Biology Ivy Tech Community College Bloomington, Indiana Main Agenda Biomanufacturing and Filtration Filtration Principles
More informationBioprocessing Challenges: High-Titer Mammalian-Based Cell Systems. Elements influencing the way Biologics may be manufactured /supplied in the future
Bioprocessing Challenges: High-Titer Mammalian-Based Cell Systems Jonathan Romero CMC Leadership, Technical Development Pharmaceutical Operations & Technology 2015 ISPE PRODUCT SHOW Business Drivers Elements
More informationApplication of Disposable Technologies in Biopharmaceutical Manufacturing
BMD Summit, Disposables for Biopharm Production 13th December 2005 Reston, VA, USA Application of Disposable Technologies in Biopharmaceutical Manufacturing Martin Wrankmore, Continuous Improvement Lead,
More informationContinuous mab Purification Process: Design Features and Practical Considerations
Continuous mab Purification Process: Design Features and Practical Considerations Joanna Pezzini CASSS DC Area Discussion Group Meeting December 7, 2017 Outline Continuous Process Overview Continuous Technologies
More informationSingle-use technology and sustainability: quantifying the environmental impact
Single-use technology and sustainability: quantifying the environmental impact Bill Flanagan Director, Ecoassessment Center of Excellence, GE 1 November 2016 Imagination at work Agenda Biopharmaceutical
More informationBuffer Make up Comparison: Continuous Inline versus Cycling Batch. Greg Lepak Craig Sandstrom
Buffer Make up Comparison: Continuous Inline versus Cycling Batch Greg Lepak Craig Sandstrom Agenda Sample Projects Model Process & Key Assumptions Buffer Estimates Equipment Flow Diagram Comparisons Process
More informationA Hands-On Guide to Ultrafiltration/Diafiltration Optimization using Pellicon Cassettes
Application Note A Hands-On Guide to Ultrafiltration/Diafiltration Optimization using Pellicon Cassettes In ultrafiltration (UF) tangential flow filtration (TFF) systems, operating parameter selection
More informationAdsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media. Dr. Robert Conway, Ph.D.
Adsorptive and Mechanical Mechanisms of Fluid Purification Using Charge Modified Depth Filtration Media Dr. Robert Conway, Ph.D. Depth Filter Cartridge Construction Zeta Plus Media Materials of Construction
More informationFiltration of Cell Culture Growth Media and Process Buffers
Customer Application Brief Bioprocess, Biologicals, & Pharmaceutical Filtration of Cell Culture Growth Media and Process Buffers Introduction Media feeds and process buffers are two universal additives
More informationENGINEERING CHALLENGES FROM THE LAB TO FACILITY
ENGINEERING CHALLENGES IN SCALING PURIFICATION FROM THE LAB TO FACILITY Christian Lim, Process Engineer CRB (Clark, Richardson, & Biskup) Consulting Engineers Boston, MA 10-May-2012 Topics Introduction
More informationA Hands-On Guide to Ultrafiltration/ Diafiltration Optimization using Pellicon Cassettes
Application Note A Hands-On Guide to Ultrafiltration/ Diafiltration Optimization using Pellicon Cassettes In ultrafiltration (UF) tangential flow filtration (TFF) systems, operating parameter selection
More informationImplementing Continuous Chromatography into DSP of Bio-Molecules
into DSP of Bio-Molecules 2014 Prep Symposium in Boston, MA Kathleen Mihlbachler Global Director of Separations Development LEWA Process Technologies kmihlbachler@lewapt.com Objective Improve the economical,
More informationApplication of Single-Use Equipment for Buffer Storage and Distribution in Medium Size mab Production Facility
Reprinted from PHARMACEUTICAL ENGINEERING THE OFFICIAL TECHNICAL MAGAZINE OF ISPE JANUARY/FEBRUARY 2014, VOL 34, NO 1 Copyright ISPE 2014 www.pharmaceuticalengineering.org facilities and equipment Application
More informationDevelopment. - Be Your Partner-
Development - Be Your Partner- 1 Product development and management 2 Product development and management A good product development is based on a strong product management. Mycenax sproject management
More informationThe Future is NOW for Continuous Manufacturing Part 3 Multi Column Continuous (MCC) Chromatography
The Future is NOW for Continuous Manufacturing Part 3 Multi Column Continuous (MCC) Chromatography Dr. Kathleen Mihlbachler Global Director of Separation Development LEWA Process Technologies 15 01 2015
More informationPerformance Evaluation and Cleanability Study using Pellicon 3 Cassettes with 30 kd Biomax and Ultracel Ultrafiltration Membranes
Application Note Performance Evaluation Cleanability Study using Pellicon Cassettes with kd Biomax Ultracel Ultrafiltration Membranes Consistent, high performance ultrafiltration throughout multiple process
More informationMulti-column Continuous Capture Chromatography New data confirming significant savings and de-bottlenecking opportunities
Multi-column Continuous Capture Chromatography New data confirming significant savings and de-bottlenecking opportunities Dr.-Ing. Kathleen Mihlbachler, LEWA Bioprocess Repligen Seminar: Advances in Bioprocessing,
More informationBPI.Seminar Semina opelmg ropelmg.com com
Send questions to: BPI.Seminars@propelmg.com Moving to the next level of Manufacturing Oct 14 th 2009 BPI Raleigh Rolf Douwenga VP Global Research and Development DSM Biologics. DSM CONFIDENTIAL FL15 Agenda
More informationKeeping up with Single-Use Geoffrey Hodge SVP Operations Unum Therapeutics 07 Oct 15
Keeping up with Single-Use Geoffrey Hodge SVP Operations Unum Therapeutics 07 Oct 15 Outline Introduction / Overview Technology Survey Economics Quality Single Use Facilities Summary 1 Introduction Disclaimer
More informationBiotech Pharmaceutical Cosmeceutical Food. Modular System Design Valves, Pumps, Fittings Heat Exchangers
Biotech Pharmaceutical Cosmeceutical Food Modular System Design Valves, Pumps, Fittings Heat Exchangers CIP Systems Bio Waste Kill Systems Purification Systems Utility Process Modules Formulation Systems
More informationFermenter System Bioreactor Lab / Pilot / Industrial Fermenter Automation Fermenter System
Fermenter System Bioreactor Lab / Pilot / Industrial Fermenter Automation Fermenter System About us CNS Co., Ltd. has reached exclusive position in fermenter development, design, and manufacturing area.
More informationSingle-use technology in downstream unit operations
Single-use technology in downstream unit operations ÄKTA ready chromatography system and more Madhu Raghunathan, Bioprocess capability days, Boston Imagination at work Presentation outline Introduction
More informationBuilding the Vaccine Manufacturing Platforms of the Future: Disposable Manufacturing. Mats Lundgren, PhD GE Healthcare Life Sciences
Building the Vaccine Manufacturing Platforms of the Future: Disposable Manufacturing Mats Lundgren, PhD GE Healthcare Life Sciences Introduction 2 Why use disposables in vaccine production? Vaccines often
More informationRecent Developments & Future Directions in the Production of Monoclonal Antibodies. Rob Noel Plasma Product Biotechnology Conference 2009, Menorca
Recent Developments & Future Directions in the Production of Monoclonal Antibodies Rob Noel Plasma Product Biotechnology Conference 2009, Menorca Forecast sales by molecule type ($m), 2006 12 600,000 Pharmaceuticals
More informationContinuous Processing Progress in Manufacturing
Cell World Conference, San Francisco, May 25-26 2017 Dr. Berthold Boedeker, Bayer AG, Biological Development Biologics at Bayer Regulatory support / drivers aof continuous processing Bayer s approach to
More informationContinuous Purity Technological, Regulatory and Validation Considerations for single-use continuous downstream processing
Marc Bisschops Tarpon Biosystems Inc. Continuous Purity Technological, Regulatory and Validation Considerations for single-use continuous downstream processing Integrated Continuous Biomanufacturing Castelldefels
More informationEconomic Impact of Single-Use Bioreactors
Economic Impact of Single-Use Bioreactors Rick Stock 2012 BIO International Convention BioProcess Theater Presentation Upstream Processing Boston, MA June 19th, 2012 BioProcess Technology Consultants www.bptc.com
More informationDesign of Membrane Filtration Systems for Biotechnology Process Applications June 19, 2003
Design of Membrane Filtration Systems for Biotechnology Process Applications June 19, 2003 Who is GEA Filtration? April 15, 2003 Template 2 Who is GEA Filtration? mg Technologies Frankfurt, Germany mg
More informationModular Turnkey Concept for Pharmaceutical Sterile Formulation Facilities
Presented at the World Batch Forum European Conference Mechelen, Belgium 11-13 October 2004 900 Fox Valley Drive, Suite 204 Longwood, FL 32779-2552 +1.407.774.5764 Fax: +1.407.774.6751 E-mail: info@wbf.org
More informationKelly Thom Associate Principal Scientist Fujifilm Diosynth Biotechnologies. Your Biologics and Vaccines CDMO Partner of Choice.
Process Design for an All Single-Use Manufacturing Facility: Scaling Low to High Titer Processes to Fit Standard mab Equipment BioProcess International West March 2, 2017 Kelly Thom Associate Principal
More informationThe Braine BioPilot An Integral Part of Bioprocess Development for Cell Culture- Based Biologics
The Braine BioPilot An Integral Part of Bioprocess Development for Cell Culture- Based Biologics Visit of Alabama Biotech Oct 2014 Alain BERNARD Vice President GPS, UCB Technical Operations Tech Ops BioTech
More informationWater Production for Pharmaceutical Manufacturing: Looking Beyond Compliance at the Entire Manufacturing Process
Water Production for Pharmaceutical Manufacturing: Looking Beyond Compliance at the Entire Manufacturing Process Grantek is a Systems Integrator focused on automation with extensive expertise and partnerships
More informationEquipment Procurement & Professional Engineering. A Winning Combo of Value & Peace of Mind
» Equipment Procurement with Professional Engineering Services The EquipNet MarketPlace is the world s largest online venue for purchasing pre-owned bio-pharmaceutical processing equipment from leading
More informationPure Process Latinoamerica S.A. de C.V. Distribuidor Exclusivo.
AUTOMATIC AND FLEXIBLE TANGENTIAL FLOW FILTRATION SYSTEM 1 KRONOS is a standalone, benchtop, automatic Tangential Flow Filtration (TFF) system offering up to 0.5 m2 total filtration area. Utilizing state
More informationQuality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends
Quality & Regulatory Issues in Biopharmaceutical Facility Design A Perspective from Industry Trends Paul Smock, Biotechnology Quality & Technical Consultant Meridian BioGroup LLC The opinions and views
More informationContinuously Improving Bioprocesses: Biopharmaceutical Capabilities
Continuously Improving Bioprocesses: Biopharmaceutical Capabilities Pall Corporation A Legacy of Innovation Dr. David B. Pall Founded by Dr. David B. Pall in 1946, Pall Corporation has grown from a company
More informationSubject Index. chromatography step, 125-
A Alert limits, description, 70 Aluminum hydroxide based vaccine manufacture, start up and validation of sterile formulation and filling processes, 144-168 Anion-exchange chromatography step for clinical-grade
More informationSummer Training Program In Industrial Biotechnology BiOZEEN, Bangalore
Summer Training Program In Industrial Biotechnology BiOZEEN, Bangalore BiOZEEN Summer Training Program in Industrial Microbiology & Fermentation Technology One small step can brighten your future Microbes
More informationBiopharm Project Solutions Inc. Process Engineering Compliance
Committed to providing reliable and expert solutions to Biologics and Pharmaceutical Projects BPS Inc, 119 Jaffrey Road, Malvern, PA, 19355 Phone: 484 614 0869 Fax: 610 296 1454 E-mail: surjs@biopharmprojects.com
More informationINSPECTION OF BIOTECHNOLOGY MANUFACTURES
PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 024-2 25 September 2007 AIDE-MEMOIRES INSPECTION OF BIOTECHNOLOGY MANUFACTURES PIC/S September 2007 Reproduction prohibited
More informationSubject Index. See for options on how to legitimately share published articles.
Downloaded via 148.251.232.83 on March 27, 2019 at 03:59:27 (UTC). See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles. A Alert limits, description, 70
More informationA Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody.
A Case Study on the Application of Disposable Technologies in cgmp Manufacturing Processes for a Therapeutic Antibody. Jeremy M Tong (presenting), Mark S Kettel, Edward M Perry, David J Pain, David M Valentine,
More informationPerfusion and Beyond The XCell TM ATF System
Perfusion and Beyond The XCell TM ATF System Earl Pineda Field Application Scientist Web ads May 9, 2018 Inspiring advances in bioprocessing since 1985 Repligen Corporation: one of the fastest-growing
More informationCross Flow Filtration Method Handbook
Cross Flow Filtration Method Handbook Page intentionally left blank Table of Contents Table of Contents 1 Introduction... 1.1 What is cross flow filtration?... 1.2 Key features of CFF... 1.3 CFF application
More informationFILTRATION SOLUTIONS PhARmAceUTIcAL manufacturing FILTRATION SPecIALISTS
FILTRATION SOLUTIONS Pharmaceutical Manufacturing filtration specialists Delivering quality filtration products As one of Europe s leading manufacturers of process filters, Amazon Filters is able to offer
More informationThe monoclonal antibody (MAb) market
Reimagining Capacity for Today s Purification of Monoclonal Antibodies Jonathan Royce The monoclonal antibody (MAb) market has grown over the past decade to be about half of the biomanufacturing market
More informationCSL s Large Scale Cell Culture Facility
BioProcess Network 20 th October 2011 CSL s Large Scale Cell Culture Facility Tim Hughes Sr. Dir. Clinical Manufacturing CSL Objective How to maximise the opportunity to build a state-of-theart facility
More informationKey Success Factors for Bioprocess Technology Selection, Scale-up & Engineering of New Facilities
Key Success Factors for Bioprocess Technology Selection, Scale-up & Engineering of New Facilities by Edi D. Eliezer Principal BioPrizM www.bioprizm.com (856) 904.2428 Key Factors for Bioprocess Technology
More informationCUNO APPLICATION BRIEF
CUNO APPLICATION BRIEF Zeta Plus Depth Filtration and Alternative Technologies for Cell Culture Clarification Introduction Production of therapeutics and diagnostics by cell culture processes has become
More informationHow single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs
WHITE PAPER 7004 How single-use connections advance aseptic processing: Increased process flexibility and reliability, reduced costs By John Boehm Business Unit Manager Colder Products Company Today s
More informationThe use of Chromatography Membranes for the development and production of biopharmaceuticals.
The use of Chromatography Membranes for the development and production of biopharmaceuticals. Dr. Juan Pablo Acosta Martinez Project Manager. Virus and Contaminant Clearance Sartorius Stedim Biotech Agenda
More informationDisposable Technologies for Purification of Biopharmaceuticals
Disposable Technologies for Purification of Biopharmaceuticals Thomas C. Ransohoff BioProcess Technology Consultants, Inc. NE Society for Industrial Microbiology Winter Meeting Boston, MA December 14,
More informationIntroduction and Background
Introduction and Background Validation of Biotech Facilities Pacific Biotech Alliance Robert J. Mackey Pacific Biotech Alliance is an established consulting firm in the Pacific Northwest that specializes
More informationbio-t bioreactor systems
bio-t bioreactor systems Bio- and Processtechnology Evolution of Technology 02 03 1. bio-t bioreactors Pure Performance In our role as plant constructor with many references in terms of customised design,
More informationAbstract Process Economics Program Report 188B BIOTECHNOLOGY SEPARATION PROCESSES (June 2002)
Abstract Process Economics Program Report 188B BIOTECHNOLOGY SEPARATION PROCESSES (June 2002) The chemical industry has a renewed interest in developing processes for producing industrial chemicals from
More informationUse of Fluidised bed chromatography for plasma fractionation. Karl McCann*, John Wu, Peter Gomme & Joseph Bertolini
Use of Fluidised bed chromatography for plasma fractionation Karl McCann*, John Wu, Peter Gomme & Joseph Bertolini Plasma Fractionation Industry Mature with well established processes Revenue growth -
More informationCOMPONENTS A full range of peripherals, accessories, probes and measuring systems and components is offered for bioreactors & fermenters.
BIOREACTORS & FERMENTERS Classical stirred tank bioreactors & fermenters suitable for microbial, yeast, algae, plant and animal cells are offered in all sizes from laboratory to production. Either as stand
More informationCONTINUOUS MANUFACTURING FOR BIOLOGICS & VACCINES
CONTINUOUS MANUFACTURING FOR BIOLOGICS & VACCINES Sue Behrens ISPE Product Show Track 2, Session 3 September 26, 2018 Questions about Continuous Bioprocessing Why? What s next? 2 1 Sue Behrens - Intro
More informationRisk Mitigation in Cell Culture: How to Prevent Viral Contamination
Platzhalter Bild Risk Mitigation in Cell Culture: How to Prevent Viral Contamination Upstream Day New Technology Platforms for Cell & Microbial Cultures May 2013 Claire Roulin, Application Specialist Purification
More informationFS 1000/3000 SIP BIOREACTORS/FERMENTORS FOR INDUSTRIAL PROCESSES
FS 1000/3000 SIP BIOREACTORS/FERMENTORS FOR INDUSTRIAL PROCESSES THE COMPANY Bionet is a specialist in bioprocesses engineering. We provide equipment (Bioreactors, Cross-Flow Filtration Systems and Cleaning-In-Place
More informationAdvancements on implementation of single use technology in vaccine manufacturing
Advancements on implementation of single use technology in vaccine manufacturing October 25 th, 2013 DCVMN Meeting Rio de Janeiro, Brazil Outline Overview of single use products Applications of single
More informationProcess Removal of Impurities in Biotech Products
Process Removal of Impurities in Biotech Products CASSS Midwest Regional Forum October 5, 2017 Warren R. Emery Sr. Research Scientist Bioproduct R&D, Eli Lilly and Company Pharmaceutical Process Development
More informationBILFINGER SE PHARMACEUTICALS AND BIOPHARMA PROJECTS: WE MAKE IT WORK FROM ENGINEERING AND TECHNOLOGY TO FABRICATION, CONSTRUCTION AND MAINTENANCE
BILFINGER SE PHARMACEUTICALS AND BIOPHARMA PROJECTS: WE MAKE IT WORK FROM ENGINEERING AND TECHNOLOGY TO FABRICATION, CONSTRUCTION AND MAINTENANCE Pharmaceuticals and Biopharma PHARMACEUTICALS AND BIOPHARMA
More informationTraining Program 2019
www.bcc.ch info@bcc.ch Biofactory Competence Center SA Passage du Cardinal 13b 1700 Fribourg (CH) Training Program 2019 Training is delivered by subject matter experts from both academia and those with
More informationUnlike chemically synthesized
Continuous Processing TECHNOLOGIES Using Technology to Overcome Bioprocessing Complexity Advanced Concentration and Analytical Technologies Accelerate Development and Manufacture of mabs, Vaccines, and
More informationAdvanced Certificate in Biopharmaceutical Manufacturing
2-Week Training Cohort: December 17-21, 2018 and January 7-11, 2019 The Advanced Certificate in Biopharmaceutical Manufacturing immerses participants in a rigorous digital and hands on training program,
More informationA dedicated DSP plant for the production of ClairYg, a LFB liquid Immunoglobulin G preparation for intravenous use
A dedicated DSP plant for the production of ClairYg, a LFB liquid Immunoglobulin G preparation for intravenous use Christophe SEGARD Technical Director Industrial Exploitation LFB 1 1 Objectives of a new
More informationCAPITAL COST ESTIMATING. 23 rd Jan 2017
CAPITAL COST ESTIMATING 23 rd Jan 2017 ESTIMATING PLANT CAPITAL COST (Projects Financial Viability) SO FAR (?):- Project has a defined technical solution Flow Sheeting NOW (?):- What is the cost of the
More informationEffluent Decontamination
Effluent Decontamination Thermal Systems BSL-1 to BSL-4 A large range for Labs and Bio-Industries MORE THAN SOLUTIONS... BATCH OR CONTINUOUS... Located in Evian, France, ACTINI has over 60 years experience
More informationQuality by Design in Critical Filtration Operations
Quality by Design in Critical Filtration Operations Michael Payne Senior Biosafety Technical Consultant Yanglin Mok Technical Manager Objectives Define quality by design (QbD) and Quality Risk Management
More informationDownstream processing is a
V E N D O RVoice Multicolumn Chromatography A New Approach to Relieving Capacity Bottlenecks for Downstream Processing Efficiency Margit Holzer, Hector Osuna-Sanchez, and Laurent David Downstream processing
More informationFiltration in Preparation of Cell Culture Media and Buffers
Filtration in Preparation of Cell Culture Media and Buffers Cell Culture Media and Buffers in Biopharmaceutical Production Cell culture media and process buffers are used in all biopharmaceutical operations.
More information2009 INVESTOR DAY. BioPharmaceuticals. Ken Frank President BioPharmaceuticals December 17, Sustainable, Profitable Growth
2009 INVESTOR DAY BioPharmaceuticals Ken Frank President BioPharmaceuticals December 17, 2009 Sustainable, Profitable Growth Life Sciences FY 2009 Total Sales $2,329.2 (amounts shown in millions) BioPharmaceuticals
More informationTechnical Report No. 61 Steam In Place
Technical Report No. 61 Steam In Place PDA Technical Report No. 61: Steam in Place Task Force Members Authors Kevin Trupp (Task Force Chair), Retired Dave Adams, Baxter Healthcare Corporation Keith E.
More informationHow to reach high plasma protein concentration with Single-Pass TFF: A case study from Baxter and
How to reach high plasma protein concentration with Single-Pass TFF: A case study from Baxter and Merck Millipore Eric Youssef Asia and Europe Plasma Market Lead Merck Millipore Bioplasma World Asia 2014
More informationCross-flow filtration for discovery, scale-up and process clarification/concentration applications
biopharmaceutical / bioindustrial Cross-flow filtration for discovery, scale-up and process clarification/concentration applications lower binding and higher yields less fouling and longer service life
More informationUsing the Sartobind pico
Using the Sartobind pico Optimizing Steps for using micro-scale membrane adsorbers on liquid chromatography systems Application Note Steps for the successful use of Sartobind pico 1. Start with a new unused
More informationProduction and Purification of Virus like particle (VLP) based Vaccine. Priyabrata Pattnaik, PhD Director Worldwide Vaccine Initiative
Production and Purification of Virus like particle (VLP) based Vaccine Priyabrata Pattnaik, PhD Director Worldwide Vaccine Initiative Outline 1 2 3 4 VLPs as Hepatitis C vaccines Baculovirus / insect cell
More informationAmazon FILTRATION SOLUTIONS PHARMACEUTICAL MANUFACTURING
Amazon FILTRATION SOLUTIONS PHARMACEUTICAL MANUFACTURING FILTRATION SOLUTIONS FOR PHARMACEUTICAL MANUFACTURING Delivering quality filtration products As one of Europe s leading manufacturers of process
More informationZeta Plus EXT ZA Series
Lenntech info@lenntech.com Tel. +31-152-61-9 www.lenntech.com Fax. +31-152-616-289 Zeta Plus The Zeta Plus filter extends depth filtration capacity and extends protection of downstream membranes thereby
More information3M Purification Inc. Filter Systems for Small Molecule Pharmaceutical Purification
3M Purification Inc. Filter Systems for Small Molecule Pharmaceutical Purification 2 Filter Systems for Pharmaceutical Separations 3M Purification Inc. Core Filtration Applications 3M Purification Inc.
More informationTrouble-shooting Fermentation and Primary recovery manufacturing issues in order to optimize antigen expression for the Vaccine business
Trouble-shooting Fermentation and Primary recovery manufacturing issues in order to optimize antigen expression for the Vaccine business Tim Lee, Ph.D. 1 Agenda Fermentation manufacturing issues in antigen
More informationThe key goal of any manufacturing. Garbage In, Garbage Out: the Case for More Accurate. Process Modeling in Manufacturing Economics
Manufacturing Economics: Process Modeling Garbage In, Garbage Out: the Case for More Accurate Process Modeling in Manufacturing Economics Rick Johnston, David Zhang Comstock Images/Getty Images abstract
More informationHigh Purity Systems. Technical and Commercial Certainty. listen create manufacture service
High Purity Systems Technical and Commercial Certainty listen create manufacture service From concept to product: We take care Listen, Create, Manufacture and Service LEWA process experts can help solve
More informationWelcome Biotech 101. Outline. Before the Floor. Manufacturing Process. Supporting Cast 4/22/2013
Welcome Biotech 101 Outline Before the Floor All the activities that happen before large scale cgmp manufacturing Manufacturing Process Manufacturing steps Equipment Requirements How it all works together
More informationDevelopment from Bench to Clinic
Accelerating Novel Vaccine Development from Bench to Clinic Roger Lias. Ph.D. President Eden Biodesign, Inc Questions Questions are encouraged and can be asked by sending an email to: edenbiodesign@propelmg.com
More informationSterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM
Sterilizing and Bioburden Filter Risk Assessment in Vaccine Processes as part of QRM DCVMN Workshop, Hyderabad, 4-8 April 2016 G. Somasundaram Associate Director - Technology Management Overview Key Regulatory
More informationSimplicity is the key Continuous purification of monoclonal antibodies
Simplicity is the key Continuous purification of monoclonal antibodies L. Landric-Burtin Head of Downstream Processing Development, France Integrated Continuous Biomanufacturing Conference, Barcelona,
More informationStainless steel or plastic? The Rentschler decision process
Stainless steel or plastic? The Rentschler decision process BPI West, March 1, 2017 Content 1 Introduction 2 Cost 3 Scale 4 Safety 5 Outlook BPI West, San Francisco February/March 2017 2 Location of the
More informationScalability of Cadence Inline Concentrator Modules for Bovine IgG Processing
Application Note USD3004 Scalability of Cadence Inline Concentrator Modules for Bovine IgG Processing Catherine Casey, M.Sc., and Engin Ayturk, Ph.D., BioPharm Applications R&D . Introduction Pall s single-pass
More informationAdvanced Certificate in Biopharmaceutical Manufacturing
2-Week Training Cohort: December 17-21, 2018 and January 7-11, 2019 The Advanced Certificate in Biopharmaceutical Manufacturing immerses participants in a rigorous digital and hands on training program,
More informationVirus Filtration for Biosimilars : From needs to Solutions
Virus Filtration for Biosimilars : From needs to Solutions 3 rd International Conference and Exhibition on Biowaivers, Biologics and Biosimilars - Hyderabad Tathagata Ray Layout of Presentation 1 Virus
More informationSartobran P 0.1 μm Sterilizing Grade Filter Cartridges
Sartobran P.1 μm Sterilizing Grade Filter Cartridges Membrane Filter Cartridges Specifications Materials Prefilter Membrane: Endfilter Membrane: Support Fleece: Core: End Caps: O-Rings:.45 μm +.1 μm Silicone
More informationThe validation of biological Active Pharmaceutical
This article presents a procedure for the validation of biological API manufacturing processes. It details each step of the procedure for biological processes applications, and covers the regulatory requirements
More informationReducing Total Cost Of Ownership In Media Filtration. White Paper. by Mandar Dixit and Chris Sullivan
Reducing Total Cost Of Ownership In Media Filtration White Paper by Mandar Dixit and Chris Sullivan Contents 3 Overview 4 Drawbacks of Existing Filter Membranes 5 New PES Membrane Technologies Specific
More informationJM BioConnect - Make the Connection
JM BioConnect - Make the Connection JM BioConnect s mission statement is to be the upstream and downstream disposable process solution specialist based on open architecture. This is not limited to single
More informationProcess economic simulation for scalable production of adenovirus
Process economic simulation for scalable production of adenovirus This application note discloses process economic modelling of a modern start-to-finish adenovirus production process. The novel process
More information